ABSTRACT
The hypercoagulable condition known as pregnancy-induced hypertension affects 5-10percent of all pregnancies and is one of the most dangerous complications. Thrombocytopenia is the most common haematological disorder seen in women with PIH and may be deadly. Elevated vascular stiffness, platelet aggregation, and coagulation system activation all contribute to pre-aberrant eclampsia’s vascular response, which in turn promotes endothelial cell failure and decreased organ perfusion. As much as 17 percent of all pregnancies are affected by it. The prevalence of PIH is estimated to be between 5 and 15% in India. Fourteen percent of all maternal deaths are caused by PIH. Two examples of suggested biological assessments are biomarkers and placental tissue. Some researchers have looked into three subjects: soluble fms-like tyrosine kinase1, soluble endoglin, and protein 13 (PP-13).
